Literature DB >> 9039297

Post-adolescent acne: a review of clinical features.

V Goulden1, S M Clark, W J Cunliffe.   

Abstract

Acne is usually recognized as a disorder of adolescence. However, the referral of patients over the age of 25 years with acne has significantly increased over the past 10 years. The clinical features of 200 patients over the age of 25 years, referred to our department for treatment of acne, were evaluated with a view to establishing possible aetiological factors. There were 152 (76%) women and 48 (24%) men. The mean age of the patients was 35.5 years (range 25-55 years). The acne was mild or moderate in severity, consisting principally of inflammatory lesions, with mean total acne grade (Leeds Grading Scale) of 1.125 for men and 0.75 for women. Most patients had persistent acne; but true late-onset acne (onset after the age of 25 years) was seen in 28 (18.4%) of women and four (8.3%) of men. Thirty-seven per cent of women had features of hyperandrogenicity. One hundred and sixty-four patients (82%) had failed to respond to multiple courses of antibiotics, and 64 (32%) had relapsed after treatment with one or more courses of isotretinoin. External factors, such as cosmetics, drugs and occupation, were not found to be significant aetiological factors. A family history revealed that 100 (50%) of patients had a first-degree relative with post-adolescent acne. Patients with post-adolescent acne appear to represent an increasingly important population of acne sufferers. External factors do not seem to have a significant aetiological role. Two main clinical groups were identified: those with persistent acne and those with late-onset acne. A minority of women also had features of hyperandrogenicity. These patients, and those with late-onset acne, may represent a subgroup who have underlying abnormalities of ovarian, adrenal or local androgen metabolism, and require separate investigation.

Entities:  

Mesh:

Year:  1997        PMID: 9039297

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  39 in total

Review 1.  Noncontraceptive health benefits of oral contraceptives.

Authors:  Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Acne and smoking.

Authors:  Bruno Capitanio; Jo Linda Sinagra; M Ottaviani; V Bordignon; A Amantea; M Picardo
Journal:  Dermatoendocrinol       Date:  2009-05

3.  The use of isotretinoin in acne.

Authors:  Alison Layton
Journal:  Dermatoendocrinol       Date:  2009-05

4.  Hormonal treatment of acne in women.

Authors:  Tobechi L Ebede; Emily L Arch; Diane Berson
Journal:  J Clin Aesthet Dermatol       Date:  2009-12

Review 5.  Acne: more than skin deep.

Authors:  J Ayer; N Burrows
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

Review 6.  [Clinical variants of acne].

Authors:  T Jansen; S Grabbe; G Plewig
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

7.  The Efficacy and Tolerability of a Fixed Combination Clindamycin (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Adult Female Patients with Facial Acne Vulgaris.

Authors:  Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2015-04

8.  Topical ALA-Photodynamic Therapy for Acne Can Induce Apoptosis of Sebocytes and Down-regulate Their TLR-2 and TLR-4 Expression.

Authors:  Eugene Jeong; Ji Won Hong; Jung Ah Min; Dong Won Lee; Mi Yeung Sohn; Weon Ju Lee; Jun Young Lee; Young Min Park
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

Review 9.  Emerging Issues in Adult Female Acne.

Authors:  Joshua A Zeichner; Hillary E Baldwin; Fran E Cook-Bolden; Lawrence F Eichenfield; Sheila Fallon-Friedlander; David A Rodriguez
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

Review 10.  Light therapies for acne.

Authors:  Jelena Barbaric; Rachel Abbott; Pawel Posadzki; Mate Car; Laura H Gunn; Alison M Layton; Azeem Majeed; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.